8-K: VSee Health Faces Nasdaq Delisting Notice Due to Delayed Quarterly Filing

VSee Health, Inc. received a notice from Nasdaq for failing to file its quarterly report on time, putting the company at risk of delisting.

Summary

• VSee Health, Inc. received a notice from Nasdaq on September 6, 2024, stating that they are not in compliance with listing rule 5250(c)(1) because they did not file their Form 10-Q for the quarter ended June 30, 2024.
• The company has 60 days, until November 5, 2024, to submit a plan to regain compliance.
• If Nasdaq accepts the plan, VSee Health may have up to 180 days from the original due date of the Form 10-Q, or until February 18, 2025, to regain compliance.
• The delay is due to ongoing valuations related to the acquisition of iDoc Virtual Telehealth Solutions, Inc. in June 2024.
• The notice does not immediately affect the listing of VSee Health's stock or warrants on the Nasdaq Capital Market.
• VSee Health intends to take the necessary steps to regain compliance as soon as possible.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice and the delay in financial reporting, indicating potential issues with the company's internal controls and financial processes. The risk of delisting is a significant concern for investors.

Positives

• The Nasdaq notice does not immediately affect the listing of the company's stock or warrants.
• The company is actively working to complete the necessary valuations and file the Form 10-Q as soon as practicable.
• VSee Health has the opportunity to submit a plan to regain compliance and potentially receive an extension until February 18, 2025.

Negatives

• VSee Health is not in compliance with Nasdaq listing rules due to the delayed filing of its quarterly report.
• The company faces a potential delisting if it fails to regain compliance within the given timeframes.
• The delay is due to complexities in valuations related to a recent acquisition, indicating potential internal challenges.

Risks

• There is a risk that Nasdaq may not accept the company's plan to regain compliance.
• If the plan is not accepted, the company may face an appeal process with a Nasdaq Hearings Panel.
• Failure to regain compliance could lead to the delisting of VSee Health's stock and warrants from the Nasdaq Capital Market.
• The ongoing valuation process related to the iDoc acquisition may present further delays or complications.

Future Outlook

The company is focused on regaining compliance with Nasdaq listing rules and filing the overdue Form 10-Q as soon as practicable, but there is no guarantee of success.

Management Comments

• The company intends to take the necessary steps to regain compliance with Nasdaq's listing rules as soon as practicable.
• All the parties are continuing working diligently to complete necessary items and file the Form 10-Q as soon as practicable.

Industry Context

The delay in filing the quarterly report highlights the challenges some companies face in integrating acquisitions and completing necessary financial valuations, which can impact their compliance with exchange listing requirements. This is not uncommon in the healthcare technology sector, where mergers and acquisitions are frequent.

Comparison to Industry Standards

• Many companies in the healthcare technology sector, such as Teladoc Health and Amwell, are expected to file their quarterly reports on time, and a delay of this nature is not typical for established public companies.
• The delay in filing the 10-Q is a significant deviation from the standard reporting practices of companies listed on the Nasdaq, which typically have robust internal controls and processes to ensure timely financial reporting.
• Compared to other companies that have undergone similar de-SPAC transactions, VSee Health's delay suggests potential issues with the integration process or financial reporting systems.

Stakeholder Impact

• Shareholders face the risk of delisting and potential loss of investment value.
• Employees may experience uncertainty due to the company's financial and compliance issues.
• Customers and suppliers may be concerned about the company's stability and future operations.
• Creditors may be concerned about the company's ability to meet its financial obligations.

Next Steps

• VSee Health needs to submit a plan to Nasdaq by November 5, 2024, to regain compliance.
• The company must complete the valuations related to the iDoc acquisition and file the Form 10-Q as soon as possible.
• VSee Health may need to appeal to a Nasdaq Hearings Panel if their plan is not accepted.

Key Dates

Keywords

Nasdaq, delisting, Form 10-Q, compliance, financial reporting, VSee Health, iDoc Virtual Telehealth Solutions, valuation, SEC, listing rules